Recent Players in the Field of Acute Myocardial Infarction Biomarkers: Circulating Cell-Free DNA or Micrornas?

Chan Chen,Junmei Xu,Feng Huang
DOI: https://doi.org/10.1016/j.ijcard.2013.03.118
IF: 4.039
2013-01-01
International Journal of Cardiology
Abstract:We read with great interest the letter recently published by Bliksøen et al. in the International Journal of Cardiology, where the authors reported for the first time that a significant increase of circulating mitochondrial DNA (mitDNA) has been observed after acute myocardial infarction (AMI) both in human and mice [1]. This is an indication for novel cardiac biomarker and therapeutic target for AMI. In fact, increased plasma cell-free DNA (cf-DNA) after AMI has also been demonstrated in several other studies [2–4].
What problem does this paper attempt to address?